Due to the special nature of medicines, returns and exchanges are not supported.

Final delivery from the nearest overseas warehous NEW

Blincyto(Blinatumomab)博纳吐单抗

Indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Categories: Breast glands and blood, Oncology drugs

Share:

Health Classification

Let us work together to protect precious health

More